

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 100.88 | 104.32 | 77.83 | 48.95 | 28.83 |
| Total Expenses | 89.76 | 100.12 | 74.49 | 51.01 | 28.47 |
| Profit Before Tax | 11.12 | 3.96 | 3.93 | -2.06 | 0.36 |
| Profit After Tax | 9.28 | 3.58 | 2.29 | -2.37 | 0.09 |
| Operating Profit After Depreciation | 13.70 | 5.90 | 5.32 | -1.03 | 0.68 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 48.69 | 35.51 | 25.92 | 16.56 | 15.99 |
| Total Non Current Assets | 54.50 | 44.68 | 26.50 | 17.35 | 16.63 |
| Total Current Assets | 69.83 | 60.65 | 47.14 | 17.35 | 13.75 |
| Total Assets | 124.33 | 105.33 | 73.64 | 34.70 | 30.38 |
| Total Shareholder's Fund | 53.25 | 45.26 | 19.46 | 2.49 | 3.06 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -4.33 | -16.08 | 8.14 | -0.31 | 0.06 |
| Net Cash Used In Investing Activities | -13.62 | -19.68 | -11.67 | -3.23 | -11.75 |
| Net Cash Used In Financing Activities | 16.09 | 29.49 | 13.14 | 3.38 | 11.40 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 64.76 | 68.42 | 58.23 | 73.36 | 43.79 |
| Total Expenses | 58.34 | 60.43 | 52.26 | 68.67 | 42.30 |
| Profit Before Tax | 6.41 | 7.76 | 5.96 | 4.69 | 1.48 |
| Profit After Tax | 4.77 | 5.75 | 4.50 | 3.30 | 1.48 |
| Operating Profit After Depreciation | 7.58 | 9 | 6.83 | 5.24 | 2.10 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 16.66 | 17.67 | 14.09 | 8.80 | 6.42 |
| Total Non Current Assets | 30.40 | 29.34 | 18.18 | 8.80 | 8.46 |
| Total Current Assets | 54.90 | 46.75 | 36.61 | 27.50 | 14.03 |
| Total Assets | 85.29 | 76.09 | 54.78 | 36.30 | 22.49 |
| Total Shareholder's Fund | 53.03 | 48.27 | 20.99 | 7.10 | 4.81 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -6.08 | -19.75 | 8.54 | 3.58 | 2.22 |
| Net Cash Used In Investing Activities | -1.89 | -12.53 | -10.93 | -3.28 | -1.07 |
| Net Cash Used In Financing Activities | 7.78 | 23.32 | 11.97 | -0.30 | -1.17 |
| Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
|---|---|---|---|---|---|
| Total Revenue | - | 25.25 | 26.45 | 25.74 | 26.67 |
| Total Expenses | - | 23.03 | 25.27 | 22.83 | 24.59 |
| Profit Before Tax | - | 1.30 | 0.30 | 1.47 | 0.68 |
| Profit After Tax | 0.42 | 1.35 | 1.51 | 0.88 | 0.21 |
| Operating Profit after Depreciation | - | 2.47 | 1.53 | 3.52 | 2.13 |
| Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
|---|---|---|---|---|---|
| Total Revenue | - | 13.01 | 16.31 | 17.68 | 14.20 |
| Total Expenses | - | 10.91 | 14 | 14.75 | 11.52 |
| Profit Before Tax | - | 1.67 | 1.86 | 2.06 | 2.15 |
| Profit After Tax | 0.86 | 1.25 | 1.38 | 1.49 | 1.67 |
| Operating Profit after Depreciation | - | 2.53 | 2.84 | 3.20 | 2.97 |
₹0.1/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
On 12 November 2025
11 Nov 2025, 09:49 am
On 29 September 2025
04 Sep 2025, 04:25 pm
Of Rs 0.1 per share
29 May 2025, 11:12 am
On 28 May 2025
24 May 2025, 08:10 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.